1 – 10 of 21
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Mutant huntingtin expression in the hypothalamus promotes ventral striatal neuropathology
2023)(
- Working paper/Preprint › Preprint in preprint archive
- 2022
-
Mark
Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models
2022)(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Hypothalamic expression of huntingtin causes distinct metabolic changes in Huntington's disease mice
(
- Contribution to journal › Article
- 2021
-
Mark
Effects of excitotoxicity in the hypothalamus in transgenic mouse models of Huntington disease
(
- Contribution to journal › Article
- 2016
-
Mark
Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease : increased NPY levels and differential degradation of the NPY1-30 fragment
(
- Contribution to journal › Article
- 2009
-
Mark
Increased orexin levels in the cerebrospinal fluid the first year after a suicide attempt.
(
- Contribution to journal › Article
-
Mark
Increased numbers of motor activity peaks during light cycle are associated with reductions in adrenergic alpha(2)-receptor levels in a transgenic Huntington's disease rat model
(
- Contribution to journal › Article
- 2008
-
Mark
Increased metabolism in the R6/2 mouse model of Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Cocaine and amphetamine regulated transcript (CART) in suicide attempters.
(
- Contribution to journal › Article
-
Mark
Islet beta-cell area and hormone expression are unaltered in Huntington's disease.
(
- Contribution to journal › Article